Patents by Inventor Jennifer H. Wilson

Jennifer H. Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Poly(diaminosulfide) particle-based vaccine
    Patent number: 11904006
    Abstract: A composition comprising particles formed of poly(diaminosulfide) and one or more leptospiral antigens, and methods of making and using the composition, are provided.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: February 20, 2024
    Assignees: University of Iowa Research Foundation, The United States of America, As Represented by The Secretary of Agriculture
    Inventors: Aliasger K. Salem, Emad I. Wafa, Sean M. Geary, Ned B. Bowden, Jennifer H. Wilson-Welder, David P. Alt
  • POLY(DIAMINOSULFIDE) PARTICLE-BASED VACCINE
    Publication number: 20210379172
    Abstract: A composition comprising particles formed of poly(diamidosulfide) and one or more leptospiral antigens, and methods of making and using the composition, are provided.
    Type: Application
    Filed: December 11, 2020
    Publication date: December 9, 2021
    Inventors: Aliasger K. Salem, Emad I. Wafa, Sean M. Geary, Ned B. Bowden, Jennifer H. Wilson-Welder, David P. Alt
  • Controlled-release immunogenic formulations to modulate immune response
    Patent number: 8173104
    Abstract: Single-dose controlled-release immunogenic formulations, such as vaccines, based on bioerodible polyanhydride copolymer or homopolymer microparticles for the control of immune response mechanisms are provided. The copolymer or homopolymer microparticles degrade by surface-erosion from in vivo hydrolysis of anhydride linkages at the surface of the microparticle, which results in controlled release of immunogen(s) to a patient.
    Type: Grant
    Filed: September 4, 2009
    Date of Patent: May 8, 2012
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Matthew J. Kipper, Balaji Narasimhan, Jennifer H. Wilson, Michael J. Wannemuehler
  • Controlled-release immunogenic formulations to modulate immune response
    Patent number: 7858093
    Abstract: Single-dose controlled-release immunogenic formulations, such as vaccines, based on bioerodible polyanhydride copolymer or homopolymer microparticles for the control of immune response mechanisms are provided. The copolymer or homopolymer microparticles degrade by surface-erosion from in vivo hydrolysis of anhydride linkages at the surface of the microparticle, which results in controlled release of immunogen(s) to a patient.
    Type: Grant
    Filed: October 28, 2005
    Date of Patent: December 28, 2010
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Matthew J. Kipper, Balaji Narasimhan, Jennifer H. Wilson, Michael J. Wannemuehler
  • CONTROLLED-RELEASE IMMUNOGENIC FORMULATIONS TO MODULATE IMMUNE RESPONSE
    Publication number: 20100021546
    Abstract: Single-dose controlled-release immunogenic formulations, such as vaccines, based on bioerodible polyanhydride copolymer or homopolymer microparticles for the control of immune response mechanisms are provided. The copolymer or homopolymer microparticles degrade by surface-erosion from in vivo hydrolysis of anhydride linkages at the surface of the microparticle, which results in controlled release of immunogen(s) to a patient.
    Type: Application
    Filed: September 4, 2009
    Publication date: January 28, 2010
    Applicant: Iowa State University Research Foundation, Inc.
    Inventors: Matthew J. Kipper, Balaji Narasimhan, Jennifer H. Wilson, Michael J. Wannemuehler